~~<i id='3DC8752B4A'><strike id='3DC8752B4A'><tt id='3DC8752B4A'><pre id='3DC8752B4A'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

author：comprehensive 2025-09-27 10:32:01 Page View：983

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Getting Alzheimer's drug Leqembi to patients can be a challenge
Next article： Cancer drug shortages should be causing more outrage

focus

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Diversity in clinical trials starts with building trust, experts say

SilasBuchanan,CEOofOurHealthyCommunity,speaksonapanelaboutdemocratizingclinicaltrialsattheMilkenInst

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

Q&A: Jennifer Adair on making gene therapy available globally

JenniferAdairdevelopsscalable,lowcostgenetherapiesattheFredHutchinsonCancerCenterandhelpedfoundtheGl